Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis. Surg Oncol Clin N Am 2015 Jan;24(1):149-66
Date
12/03/2014Pubmed ID
25444473DOI
10.1016/j.soc.2014.09.004Scopus ID
2-s2.0-84922895425 (requires institutional sign-in at Scopus site) 12 CitationsAbstract
Management of liver malignancies, both primary and metastatic, requires a host of treatment modalities when attempting to prolong survival. Although surgical resection and transplantation continue to offer the best chance for a cure, most patients are not amenable to these therapies because of their advanced disease at presentation. Taking advantage of the unique blood supply of the liver, transarterial chemoembolization has emerged as an alternative and effective therapy for unresectable tumors. In this article, the current role along with future perspectives of transarterial chemoembolization for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and colorectal liver metastasis are discussed.
Author List
Miura JT, Gamblin TCAuthor
Thomas Clark Gamblin MD Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antineoplastic AgentsCarcinoma, Hepatocellular
Chemoembolization, Therapeutic
Colorectal Neoplasms
Hepatic Artery
Humans
Liver Neoplasms
